Both in Biotechnology
PharmaCyte Biotech vs Senti Biosciences Holdings
Over the past year PMCB returned −67.5% and SNTI returned −91.9%; their daily moves had a correlation of 0.17.
PMCB −67.5% SNTI −91.9%Growth of $1, one year, split-adjusted
| Metric | PMCB | SNTI |
|---|---|---|
| Price | $0.3021 | $0.1651 |
| Market cap | $3.2M | $6.3M |
| Today | −9.03% | −23.92% |
| 1 month | −25.2% | −49.1% |
| 6 months | −60.0% | −83.8% |
| Year to date | −58.3% | −84.1% |
| 1 year | −68.5% | −92.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −75000.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 115.4× |
| Net cash | $30.5M | $2.5M |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 111.5% |
| Short % of float | 0.8% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).